Australia · Delayed Price · Currency is AUD EMVision Medical Devices Earnings Call Transcripts
Fiscal Year 2026
-
A novel portable brain scanner using radio frequency signals is advancing stroke and brain injury care, with strong clinical data, major partnerships, and a robust patent portfolio. Market entry is focused on hospitals and ambulances, with pivotal trials supporting regulatory submissions.
-
Portable brain scanners for stroke and traumatic brain injury are nearing pivotal trial completion, with strong clinical data and a U.S. launch targeted for 2027. The company is leveraging industry partnerships, robust IP, and a scalable business model to address large global markets.
Fiscal Year 2025
-
Transitioning to commercialization, two neurodiagnostic devices are advancing through pivotal clinical trials and regulatory pathways, targeting major U.S. and international markets. Strategic partnerships, robust funding, and a phased launch plan underpin growth, with multiple clinical and regulatory milestones ahead.